BRAIN METASTASIS AND HER-2 STATUS IN METASTATIC BREAST CANCER (MBC) IN OMAN

被引：0
|
作者：
Monem, E. Abdul [1 ]
Mehdi, I. [1 ]
Al Bahrani, B. [1 ]
机构：
[1] Royal Hosp, Muscat, Oman
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
121P
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [1] Incidence of brain metastasis (BM) in HER-2 overexpressing metastatic breast cancer (MBC) responsive to trastuzumab
    Stemmler, J
    Kahlert, S
    Siekiera, W
    Heinrich, B
    Untch, M
    Heinemann, V
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S130 - S130
  • [2] Evaluation of serum HER-2 level as a surrogate marker for an accurate assessment of the HER-2 status in the management of metastatic breast cancer (MBC)
    Tse, C
    Gligorov, J
    Brault, D
    Dollivet, G
    Neumann, R
    Capeau, J
    Lotz, JP
    CLINICA CHIMICA ACTA, 2005, 355 : S431 - S431
  • [3] Prediction of brain relapse (BR) in HER-2 positive metastatic breast cancer (MBC) patients (pts)
    Duchnowska, R.
    Czartoryska-Arlukowicz, B.
    Radecka, B.
    Szostakiewicz, B.
    Sosinska, K.
    Karpinska, A.
    Dziadziuszko, R.
    Staroslawska, E.
    Kubiatowski, T.
    Sczylik, C.
    EJC SUPPLEMENTS, 2007, 5 (04): : 213 - 213
  • [4] HER-2 status influences survival in a rat model of brain metastasis from breast cancer
    Hunt, M. A.
    Muldoon, L. L.
    Palmieri, D.
    Steeg, P. S.
    Neuwelt, E. A.
    NEURO-ONCOLOGY, 2006, 8 (04) : 472 - 472
  • [5] Her-2 overexpression promotes the brain metastasis of breast cancer.
    Steeg, P. S.
    Palmieri, D.
    Bronder, J. L.
    Herring, J. L.
    Halverson, D.
    Vega-Valle, E.
    Feigenbaum, L.
    Yoneda, T.
    Weil, R. J.
    Stark, A. M.
    Vortmeyer, A. O.
    Kurek, R.
    Aldape, K.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S206 - S207
  • [6] Trastuzumab (T) and CNS metastases in women with HER-2 positive metastatic breast cancer (MBC).
    Dawson, SJJ
    Ranieri, NF
    Snyder, RD
    McLachlan, SAA
    Burns, WI
    Newnham, GM
    Francis, PA
    Dowling, AJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 49S - 49S
  • [7] Pattern of brain metastatic disease according to HER-2 and ER receptor status in breast cancer patients
    Lekanidi, K.
    Evans, A. L.
    Shah, J.
    Jaspan, T.
    Baker, L.
    Evans, A. J.
    CLINICAL RADIOLOGY, 2013, 68 (10) : 1070 - 1073
  • [8] Her-2 Status on Primary Breast Cancer and Concurrent Lymph Node Metastasis
    Loona, A.
    Dosanj, P.
    Deb, R.
    JOURNAL OF PATHOLOGY, 2015, 237 : S30 - S30
  • [9] Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)
    Giuliani, Rosa
    Durbecq, Virginie
    Di Leo, Angelo
    Paesmans, Marianne
    Larsimont, Denis
    Leroy, Jean-Yves
    Borms, Marleen
    Vindeuoghel, Anita
    Jerusalem, Guy
    D'Hondt, Veronique
    Dirix, Luc
    Canon, Jean-Luc
    Richard, Vincent
    Cocquyt, Veronique
    Majois, Francoise
    Reginster, Michel
    Demol, Jan
    Kains, Jean-Pierre
    Delree, Paul
    Keppens, Carine
    Sotiriou, Christos
    Piccart, Martine J.
    Cardoso, Fatima
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (04) : 725 - 735
  • [10] Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain
    Palmieri, Diane
    Bronder, Julie L.
    Herring, Jeanne M.
    Yoneda, Toshiyuki
    Weil, Robert J.
    Stark, Andreas M.
    Kurek, Raffael
    Vega-Valle, Eleazar
    Feigenbaum, Lionel
    Halverson, Douglas
    Vortmeyer, Alexander O.
    Steinberg, Seth M.
    Aldape, Kenneth
    Steeg, Patricia S.
    CANCER RESEARCH, 2007, 67 (09) : 4190 - 4198
12345